Christopher Rowbottom
Impact in
-
- Drug Transport and Resistance Mechanisms
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 4
-
- Melanoma and MAPK Pathways 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Guangqing Xiao (4 shared papers)Cornelis E. C. A. Hop (3 shared papers)Yurong Lai (3 shared papers)Jashvant D. Unadkat (3 shared papers)Laurent Salphati (3 shared papers)Xiaoyan Chu (3 shared papers)W. Griffith Humphreys (3 shared papers)Bhagwat Prasad (2 shared papers)
- Journals
- Drug Metabolism and Disposition (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Molecular Pharmacology (1 paper)Pharmacology Research & Perspectives (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesJapanChina
In The Last Decade
Christopher Rowbottom
9 papers receiving 366 citations
Peers
Comparison fields: 5 of 63
- Oncology 150
- Pharmacology 47
- Immunology 73
- Pediatrics, Perinatology and Child Health 61
- Pharmaceutical Science 18
Countries citing papers authored by Christopher Rowbottom
This map shows the geographic impact of Christopher Rowbottom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Rowbottom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Rowbottom more than expected).
Fields of papers citing papers by Christopher Rowbottom
This network shows the impact of papers produced by Christopher Rowbottom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Rowbottom. The network helps show where Christopher Rowbottom may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Rowbottom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 116 | |
| 2 | 2019 | 64 | |
| 3 | 2017 | 52 | |
| 4 | 2014 | 48 | |
| 5 | 2020 | 31 | |
| 6 | 2008 | 24 | |
| 7 | 2021 | 14 | |
| 8 | 2011 | 10 | |
| 9 | 2018 | 9 |
About Christopher Rowbottom
Christopher Rowbottom is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine and Epidemiology, having authored 9 papers that have together received 368 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Pharmacogenetics and Drug Metabolism (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Melanoma and MAPK Pathways (1 paper), T-cell and B-cell Immunology (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (150 citations), Pharmacology (47 citations), Immunology (73 citations), Pediatrics, Perinatology and Child Health (61 citations) and Pharmaceutical Science (18 citations). Christopher Rowbottom has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Guangqing Xiao, Cornelis E. C. A. Hop, Yurong Lai, Jashvant D. Unadkat, Laurent Salphati, Xiaoyan Chu, W. Griffith Humphreys, Bhagwat Prasad, Sarah Billington and Raymond Evers. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Molecular Pharmacology, Pharmacology Research & Perspectives and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.